ADVFN ADVFN

Hot Features

Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
KalVista Pharmaceuticals Inc

KalVista Pharmaceuticals Inc (KALV)

26,95
0,00
(0,00%)
Fermé 06 Juin 10:00PM
26,9504
0,0004
(0,00%)
Après les heures de négociation: 1:04AM

KalVista Pharmaceuticals Inc (KALV) Répartition de la Propriété

Institutions
102.02%
Initiés
1.77%
Public et Autres
-3.79%

KalVista Pharmaceuticals Inc (KALV) Propriété

Actionnaire Type Détenues (Réel) % en Circulation Valeur Marchande Date de Reporte
VR Management, LLCInstitution6 474 48512,16%US$ 174,49M2026-03-31
Suvretta Capital Management, LLCInstitution4 768 7128,96%US$ 128,52M2026-03-31
Tang Capital Management, LLCInstitution4 573 5308,59%US$ 123,26M2026-03-31
Averill Master Fund, Ltd.Institution3 971 0257,46%US$ 107,02M2024-09-30
Venrock Healthcare Capital Partners EG, L.P.Institution3 883 1927,29%US$ 104,65M2026-03-26
BlackRock, Inc.Institution3 795 8597,13%US$ 102,30M2026-03-31
Silverarc Capital Management, LLCInstitution2 876 4075,40%US$ 77,52M2026-03-31
Capital Research and Management CompanyInstitution2 808 5835,28%US$ 75,69M2026-03-31
Point72 Associates, LLCInstitution2 781 9025,23%US$ 74,97M2026-01-05
Point72 Asset Management, L.P.Institution2 136 9404,01%US$ 57,59M2026-03-31
Emerald Advisers, LLCInstitution2 069 7853,89%US$ 55,78M2026-03-31
State Street Global Advisors, Inc.Institution1 955 8443,67%US$ 52,71M2026-03-31
Millennium Management LLCInstitution1 912 1463,59%US$ 51,53M2026-03-31
Medical Strategy GmbHInstitution1 876 6503,52%US$ 50,58M2025-12-31
Vestal Point Capital, LPInstitution1 850 0003,47%US$ 49,86M2026-03-31
Parkman Healthcare Partners LLCInstitution1 835 5063,45%US$ 49,47M2026-03-31
Vanguard Capital Management, LLCInstitution1 830 4673,44%US$ 49,33M2026-03-31
Frazier Life Sciences Management, LPInstitution1 829 3033,44%US$ 49,30M2026-05-19
Kynam Capital Management, LPInstitution1 820 9543,42%US$ 49,07M2026-03-31
Integrated Core Strategies (US) LLCInstitution1 546 1052,90%US$ 41,67M2026-03-31
Woodline Partners LPInstitution1 509 9202,84%US$ 40,69M2026-03-31
Octagon Capital Advisors LPInstitution1 450 0002,72%US$ 39,08M2026-03-31
Frazier Life Sciences Public Fund, L.P.Institution1 249 1652,35%US$ 33,66M2026-05-19
Armistice Capital LLCInstitution1 236 0002,32%US$ 33,31M2026-03-31
Venrock Healthcare Capital Partners III, L.P.Institution1 096 4782,06%US$ 29,55M2026-03-26
Elmind Capital, L.P.Institution1 021 3001,92%US$ 27,52M2026-03-31
Geode Capital Management, LLCInstitution996 2351,87%US$ 26,85M2026-03-31
Squadron Capital Management LlcInstitution985 1001,85%US$ 26,55M2026-03-31
Frazier Life Sciences Public Overage Fund, L.P.Institution946 0741,78%US$ 25,50M2025-08-18
Spruce Street Capital LPInstitution897 6811,69%US$ 24,19M2026-03-31
Freestone Grove Partners LPInstitution882 9061,66%US$ 23,79M2026-03-31
The Goldman Sachs Group, Inc.Institution751 3181,41%US$ 20,25M2026-03-31
Great Point Partners, LLCInstitution675 0001,27%US$ 18,19M2026-03-31
BNY Asset ManagementInstitution584 3471,10%US$ 15,75M2026-03-31
Driehaus Capital Management LLCInstitution564 0391,06%US$ 15,20M2026-03-31
UBS Asset Management AGInstitution550 3931,03%US$ 14,83M2026-03-31
Barclays PLCInstitution536 5381,01%US$ 14,46M2026-03-31
Schroder Investment Management LimitedInstitution506 7430,95%US$ 13,66M2026-03-31
Bank of America CorporationInstitution491 5190,92%US$ 13,25M2026-03-31
Mr. Benjamin PalleikoInitiés479 9890,90%US$ 12,94M2026-05-22
Frazier Life Sciences X, L.P.Institution427 9830,80%US$ 11,53M2026-05-19
Catalio Capital Management, LPInstitution426 5510,80%US$ 11,50M2026-03-31